GGrantIndex
Sort

39,280 grants matching leukemia

Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy

$340,838
Srividya Bhaskara · University Of Utah · R01 · FY2017 · CA

New Triterpenoids for Chemoprevention and Therapy of Cancer

$340,825
Michael B Sporn · Dartmouth College · R01 · FY2012 · CA

New Triterpenoids for Chemoprevention and Therapy of Cancer

$340,825
Michael B Sporn · Dartmouth College · R01 · FY2011 · CA

The role of AKT signaling in NOTCH1 induced leukemias

$340,819
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2008 · CA

Identifying and targeting evolutionary trajectories in cancer

$340,788
Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2020 · CA

Inflammatory and immune dysregulation associated lung disease

$340,762
Kenneth Olivier · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

New perspective on MyoD function and differentiation in rhabdomyosarcoma

$340,712
Denis C Guttridge · Medical University Of South Carolina · R01 · FY2022 · CA

Colorectal Cancer

$340,689
Mark J Ratain · University Of Chicago · U01 · FY2007 · GM

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT

$340,670
Effie W Petersdorf · Fred Hutchinson Cancer Research Center · U01 · FY2014 · CA

ROLE OF PBX AND PRE B ACUTE LYMPHOBLASTOID LEUKEMIA

$340,647
University Of California San Diego · R01 · FY2004 · CA

Cellular Imaging and Molecular Pathology

$340,582
Christopher H Contag · Stanford University · P01 · FY2010 · CA

Molecular Characterization of Stage I Lung Cancer

$340,529
Ming You · Washington University · R01 · FY2008 · CA

MOLECULAR CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA

$340,493
Stanford University · R01 · FY2001 · CA

Metabolism and Toxicity of Arsenic in the Human Liver

$340,472
Miroslav Styblo · Univ Of North Carolina Chapel Hill · R01 · FY2009 · ES

Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow

$340,471
Damian J. Green · Fred Hutchinson Cancer Research Center · R21 · FY2012 · CA

Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.

$340,461
David Porter · University Of Pennsylvania · P01 · FY2020 · CA

Hematopoietic Regulation via GATA Switches

$340,434
Emery H. Bresnick · University Of Wisconsin-Madison · R01 · FY2020 · DK

Hematopoietic Regulation via GATA Switches

$340,434
Emery H. Bresnick · University Of Wisconsin-Madison · R01 · FY2017 · DK

Hematopoietic Regulation via GATA Switches

$340,434
Emery H. Bresnick · University Of Wisconsin-Madison · R01 · FY2016 · DK

Hematopoietic Regulation via GATA Switches

$340,434
Emery H. Bresnick · University Of Wisconsin-Madison · R01 · FY2019 · DK

Survival Mechanisms in Leukemic NK Cells

$340,427
Thomas P Loughran · University Of Virginia · R01 · FY2015 · CA

Stem Cell Gene Therapy for AIDS

$340,425
Harvard University (Medical School) · R01 · FY2005 · CA

Stem Cell Gene Therapy for AIDS

$340,425
Harvard University (Medical School) · R01 · FY2003 · CA

Development of AMPK Inhibitors for the treatment of leukemia

$340,418
Philip Reigan · University Of Colorado Denver · R01 · FY2023 · CA

Olig2 Antagonists for Targeted Therapy of Pediatric Astrocytomas

$340,394
Charles Stiles · Dana-Farber Cancer Inst · P01 · FY2014 · CA